Association of frailty status with risks of Urinary Incontinence. by Xiaohan Gan (22097061)

Subjects:

Subgroup analyses for the association of frailty status with risks of Urinary Incontinence by potential mediators. by Xiaohan Gan (22097061)

Subjects:

Stress-strain and ring stiffness curves of ABR pipes. by Changxi Shan (22493205)

Subjects:

ABR pipe circumferential stress at location-1 loading. by Changxi Shan (22493205)

Subjects:

A trend in discussions about the endemic blues and daily responsibilities. by Seoyoung Kim (2603596)

Mean concentrations of sum sesquiterpenes and single sesquiterpenes: β-caryophyllene, α-humulene, δ-selinene, γ-cadinene, δ-cadinene, nerolidol, maaliol, germacrene D-4-ol, spathul... by Valtcho D. Zheljazkov (627617)

Ingenuity pathway analysis of tonic ISG subclasses. by Tyron Chang (9922533)

DEGs and enrichment analysis in HepG2 cells expressing HBx. by Jianhua Zhong (11351726)

Study design and plasma viral load. by Zoey K. Wallis (17725175)

Metric correlation matrix. by Chao Song (379006)

Comparative analysis of hospital information recognition metrics between intervention and control groups across six hospitals. by Chao Song (379006)

Table 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.doc... by Yiping Cao (1229856)

“…Pharmacological activation of local PVT A_2AR with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”

Image 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

“…Pharmacological activation of local PVT A_2AR with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”

Image 2_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

“…Pharmacological activation of local PVT A_2AR with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”

(A) The overexpression of PRDX1 reduces the intracellular ROS level. by Jing Chen (4762)

“…After overexpression of chIRAP, the intensity of red fluorescence in mitochondria decreased significantly, while the green fluorescence increased significantly. …”

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…</p><p>Conclusions</p><p>Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.…”

F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype. by Keifer G. Kurtz (21416918)

“…CD163 MFI is significantly decreased with F05 treatment (p = 0.0089, 55% decrease), but not 1H9 (p = 0.0828, 31% decrease) when compared to RITUX.…”

Variable evaluation and construction of a prognostic nomogram. by Kai Yang (73590)

Table 1_DYRK1A roles in human neural progenitors.xlsx by Jeremie Courraud (20871932)

“…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”

Data Sheet 1_DYRK1A roles in human neural progenitors.docx by Jeremie Courraud (20871932)

“…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”